313 results on '"Hu, Kuan"'
Search Results
2. Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β
3. Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis
4. l-[5-11C]Glutamine PET imaging noninvasively tracks dynamic responses of glutaminolysis in non-alcoholic steatohepatitis
5. Enhanced radiotheranostic targeting of integrin α5β1 with PEGylation-enabled peptide multidisplay platform (PEGibody): A strategy for prolonged tumor retention with fast blood clearance
6. A 211At-labelled mGluR1 inhibitor induces cancer senescence to elicit long-lasting anti-tumor efficacy
7. Postoperative recurrent jaundice and fever: A deceptive case caused by hemobilia
8. A multifunctional nanotheranostic agent potentiates erlotinib to EGFR wild-type non-small cell lung cancer
9. PEIGel: A biocompatible and injectable scaffold with innate immune adjuvanticity for synergized local immunotherapy
10. Peptide-based nanomaterials: Self-assembly, properties and applications
11. An integrative pan cancer analysis of RET aberrations and their potential clinical implications
12. Dexmedetomidine promotes apoptosis and suppresses proliferation of hepatocellular carcinoma cells via microRNA-130a/EGR1 axis
13. Combined positron emission tomography‐guided modified black phosphorus nanosheet‐based photothermal therapy and anti programmed cell death protein ligand 1 therapy
14. Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals
15. Synthesis and preliminary evaluation of novel 11C-labeled GluN2B-selective NMDA receptor negative allosteric modulators
16. Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers.
17. Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers
18. Back Cover: Integration of organoids in peptide drug discovery: Rise of the high‐throughput screening (View 6/2023)
19. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
20. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study
21. Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT
22. Analysis of contact ablation of circuit breaker after short circuit current breaking
23. Study on the flashover mechanism of bird droppings in the transmission line
24. Development of Novel 11C-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography Imaging
25. In situ observation of grain-boundary development from a facet-facet groove during solidification of silicon
26. Correction to: A Hybrid Biofuel and Triboelectric Nanogenerator for Bioenergy Harvesting
27. A Hybrid Biofuel and Triboelectric Nanogenerator for Bioenergy Harvesting
28. The ubiquitin‐specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression
29. MoS2-decorated coaxial nanocable carbon aerogel composites as cathode materials for high performance lithium-sulfur batteries
30. Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection
31. Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy
32. Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: a retrospective cohort study
33. HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p
34. Integration of organoids in peptide drug discovery: Rise of the high‐throughput screening.
35. Severe polycystic liver diseases: hepatectomy or waiting for liver transplantation?: Two case reports
36. Editorial: Self-assembled biodegradable materials for medical sensing, diagnosis, and therapy
37. Structural analysis of the dodecameric proteasome activator PafE in Mycobacterium tuberculosis
38. Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study
39. The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis
40. Polypyrrole-Stabilized Polypeptide for Eco-Friendly Supercapacitors
41. An adenosine triphosphate-independent proteasome activator contributes to the virulence of Mycobacterium tuberculosis
42. Downregulated PRNP Facilitates Cell Proliferation and Invasion and Has Effect on the Immune Regulation in Ovarian Cancer
43. ALKBH family members as novel biomarkers and prognostic factors in human breast cancer
44. Downregulated ferroptosis‐related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma
45. Recent Progress on Graphene Flexible Photodetectors
46. The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma
47. Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
48. GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
49. Whole-body PET tracking of a d-dodecapeptide and its radiotheranostic potential for PD-L1 overexpressing tumors
50. Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.